In ALK-rearranged NSCLC, fusion proteins such as EML4-ALK promote continuous activation of downstream signaling pathways including MAPK, PI3K-AKT-mTOR, and JAK-STAT leading to uncontrolled cell proliferation. The gene discussed is ALK; the disease is non-small cell lung carcinoma.